Skip to main content
Explore URMC

URMC Logo

URMC / Research / Research@URMC
Pancreatic Cancer Network Awards $2M to Wilmot Investigator

Pancreatic Cancer Network Awards $2M to Wilmot Investigator

The national Pancreatic Cancer Action Network (PANCAN) granted its most competitive award, for $2 million, to David C. Linehan, M.D., to support a large, multicenter clinical trial testing an immunotherapy in patients with metastatic pancreatic cancer.

7/13/2016
Center for Musculoskeletal Research Renews $4 Million Grant from NIH and Launches the Brodell Musculoskeletal Research Fund

Center for Musculoskeletal Research Renews $4 Million Grant from NIH and Launches the Brodell Musculoskeletal Research Fund

The Center for Musculoskeletal Research at the URMC has received renewal of a five year, $4 million grant from the NIH. This grant in combination with philanthropic funding, like the newly named Harold Louis Brodell, M.D. ’54 and Alma Jean Brodell Musculoskeletal Research Fund, will allow the CMSR to continue to develop its most valuable resource: its research talent. 

6/29/2016
Proposed Loan Forgiveness Changes Could Heighten Primary Care Shortage

Proposed Loan Forgiveness Changes Could Heighten Primary Care Shortage

A new study led by URMC neurology resident Ben George, M.D., M.P.H. appearing in the Journal of General Internal Medicine argues that the a proposed cap in federal loan forgiveness program could have the unintended consequence of dissuading medical students from pursuing careers in primary care. 

6/27/2016
Review: Giving Gene Editing Technology CRISPR-Cas9 a Boost

Review: Giving Gene Editing Technology CRISPR-Cas9 a Boost

A new gene editing technology called CRISPR-Cas9 allows researchers to quickly and easily make changes to the DNA of humans, animals and plants. Scientists in the University of Rochester Center for RNA Biology highlight a cellular mechanism that can help users employ the technique with more precision. 

6/16/2016
From Flu to Smallpox, URMC Clinical Trials Lead the Way to Vaccines

From Flu to Smallpox, URMC Clinical Trials Lead the Way to Vaccines

The Vaccine Research Unit at the University of Rochester Medical Center began conducting vaccine trials in the 1970s. Their work has led to the approval of new flu vaccines and the first and only vaccine to prevent cancer and continues today with studies of bird flu and norovirus. 

6/9/2016